<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30360728</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>26</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1875-5992</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>25</Day>                    </PubDate>                </JournalIssue>                <Title>Anti-cancer agents in medicinal chemistry</Title>                <ISOAbbreviation>Anticancer Agents Med Chem</ISOAbbreviation>            </Journal>            <ArticleTitle>Immunohistochemical expression of melatonin receptor MT1 and glucose transporter GLUT1 in human breast cancer.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.2174/1871520618666181025125532</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Breast cancer is a heterogeneous disease and is the leading cause of cancer-related deaths among women. Even after diagnosis, the prognosis cannot be concluded since patients can develop resistance to therapy, which favors tumor growth, invasion and metastasis. In e recent years, research has focused on identifying significant markers that can be used to determine the prognosis. Melatonin can act through G protein-coupled MT1 receptor, which controls selected protein kinases, influences the levels of transcription factor phosphorylation, specific genes expression, proliferation, angiogenesis, cell differentiation, migration, and indirectly controls the transport of glucose in cancer cells. It is known that glucose enters the cells by glucose transporters, such as GLUT1 which shows wide tissue distribution and appears to be altered in human breast carcinoma. High GLUT1 expression is associated with increased malignant potential, invasiveness and poor prognosis in some cancers including breast cancer.</AbstractText>                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to evaluate the expression of MT1 receptor and GLUT1 in breast tumors and correlate with molecular subtypes and prognostic characteristics.</AbstractText>                <AbstractText Label="METHOD" NlmCategory="METHODS">Protein expression was performed by an immunohistochemical procedure with specific antibodies and positive and negative controls.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that MT1 high expression was associated with good prognosis subtype (Luminal A), while GLUT1 high expression was related with poor prognosis subtype (triple-negative). In addition, we found high expression of MT1 in ER+ and the inverse in GLUT1 expression. GLUT1 is also highly expressed in tumor ≥20mm.</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results indicate MT1 and GLUT1 as potential targets for breast cancer subtypes and prognosis.</AbstractText>                <CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>de Castro</LastName>                    <ForeName>Tialfi Bergamin</ForeName>                    <Initials>TB</Initials>                    <AffiliationInfo>                        <Affiliation>UNESP - Universidade Estadual Paulista - Cristóvão Colombo Street, 2265 - 15054-000 - São José do Rio Preto, São Paulo. Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Lima Mota</LastName>                    <ForeName>André</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>FAMERP - São José do Rio Preto Medical School - Av. Brigadeiro Faria Lima, 5416 - 15091-200 - São José do Rio Preto, São Paulo. Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Bordin-Junior</LastName>                    <ForeName>Newton Antônio</ForeName>                    <Initials>NA</Initials>                    <AffiliationInfo>                        <Affiliation>Hospital de Base de São José do Rio Preto - Av. Brigadeiro Faria Lima, 5416 - 15091-200 - São José do Rio Preto, São Paulo. Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Santi Neto</LastName>                    <ForeName>Dalisio</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Hospital de Base de São José do Rio Preto - Av. Brigadeiro Faria Lima, 5416 - 15091-200 - São José do Rio Preto, São Paulo. Brazil.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>de Campos Zuccari</LastName>                    <ForeName>Debora Aparecida Pires</ForeName>                    <Initials>DAP</Initials>                    <AffiliationInfo>                        <Affiliation>UNESP - Universidade Estadual Paulista - Cristóvão Colombo Street, 2265 - 15054-000 - São José do Rio Preto, São Paulo. Brazil.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>25</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Netherlands</Country>            <MedlineTA>Anticancer Agents Med Chem</MedlineTA>            <NlmUniqueID>101265649</NlmUniqueID>            <ISSNLinking>1871-5206</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">GLUT1</Keyword>            <Keyword MajorTopicYN="N">MT1</Keyword>            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">diagnosis</Keyword>            <Keyword MajorTopicYN="N">melatonin</Keyword>            <Keyword MajorTopicYN="N">prognosis</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>07</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30360728</ArticleId>            <ArticleId IdType="pii">ACAMC-EPUB-93988</ArticleId>            <ArticleId IdType="doi">10.2174/1871520618666181025125532</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>